QIM
BCRX icon

Quantitative Investment Management’s BioCryst Pharmaceuticals BCRX Stock Holding History

Quantitative Investment Management’s Portfolio BCRX Stock Details BCRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-10,677
Closed -$134K – 220
2022
Q3 		$134K Buy
+10,677
New +$137K 0.02% 264
2022
Q2 		– Sell
-21,035
Closed -$342K – 217
2022
Q1 		$342K Buy
+21,035
New +$337K 0.04% 160
2021
Q1 		– Sell
-256,210
Closed -$1.91M – 501
2020
Q4 		$1.91M Buy
+256,210
New +$1.32M 0.15% 155
2020
Q3 		– Sell
-77,301
Closed -$368K – 403
2020
Q2 		$368K Buy
+77,301
New +$309K 0.04% 387
2020
Q1 		– Sell
-24,704
Closed -$85K – 522
2019
Q4 		$85K Sell
24,704
-4,245
-15% -$10.7K ﹤0.01% 605
2019
Q3 		$82K Buy
+28,949
New +$90K ﹤0.01% 569
2019
Q1 		– Sell
-23,800
Closed -$192K – 650
2018
Q4 		$192K Buy
+23,800
New +$185K 0.01% 497
2018
Q3 		– Sell
-74,800
Closed -$428K – 644
2018
Q2 		$428K Buy
+74,800
New +$412K 0.01% 624
2016
Q2 		– Sell
-103,800
Closed -$293K – 743
2016
Q1 		$293K Buy
+103,800
New +$460K 0.01% 639
2015
Q4 		– Sell
-19,100
Closed -$217K – 689
2015
Q3 		$217K Buy
19,100
+1,800
+10% +$24K 0.02% 596
2015
Q2 		$258K Buy
+17,300
New +$197K 0.04% 344
2014
Q2 		– Sell
-11,500
Closed -$121K – 467
2014
Q1 		$121K Buy
+11,500
New +$123K 0.01% 498

Other funds holding BCRX

AWA
Arete Wealth Advisors Chicago, Illinois $1.33B AUM 25.12% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PAMS
Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
RM
RP Management New York $139M AUM 37.98% 1-Year Est. Return

Quantitative Investment Management's BCRX Position: Q4 2022 in Review

Quantitative Investment Management sold out of BioCryst Pharmaceuticals (BCRX) in Q4 2022, closing a stake of 10,677 shares — an estimated $134K sold.

Quantitative Investment Management first reported a position in BCRX in Q1 2014 and held it in 12 quarters. The position peaked at $1.91M in Q4 2020. 230 funds tracked by Wall St. Rank hold BCRX as of Q4 2022.

  • Quantitative Investment Management reported no remaining BioCryst Pharmaceuticals position as of Q4 2022 after selling out during the quarter.
  • Quantitative Investment Management sold 10,677 BioCryst Pharmaceuticals shares in Q4 2022, an estimated $134K.
  • Quantitative Investment Management first reported a position in BioCryst Pharmaceuticals in Q1 2014 and held it in 12 quarters.
  • Quantitative Investment Management's BioCryst Pharmaceuticals position peaked at $1.91M in Q4 2020.
  • 230 funds tracked by Wall St. Rank held BioCryst Pharmaceuticals as of Q4 2022.

Based on Quantitative Investment Management's 13F filing for Q4 2022, filed 14 Feb 2023.